Answers are grounded in this paper and cite their sources.
Pilot study demonstrates estrogen deficit score predicts cardiovascular risk in postmenopausal women, indicating new assessment methods.
Objectives: Menopause is a state of estrogen deficit that predisposes to metabolic derangements in the lipid profile and release of inflammatory mediators such as C-reactive protein (CRP) that leads to cardiovascular complications. Hence, this study was intended to assess the lipid and inflammatory markers in postmenopausal women (postMPW) and to calculate the estrogen deficit score (EDS) to assess the cardiovascular risk. Materials and Methods: This is a cross-sectional study involving 50 premenopausal women (pre-MPW) and 50 post-MPW aged more than 55 years. The levels of total cholesterol (TC), triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), Very low density lipoprotein (VLDL), and CRP were compared between the pre-MPW and post-MPW using Independent Student’s t-test. The cardiovascular risk in post-MPW was calculated using a risk assessment score called EDS that was calculated using the following formula (Age × CRP)/HDL. Results: The mean CRP level in pre-MPW is 2.8 ± 1.8 and in post-MPW is 6.2 ± 5.4 and the difference was statistically significant. EDS was significantly high in post-MPW than pre-MPW (10.5 ± 8.0 vs. 1.9 ± 0.6, P < 0.001). In post-MPW, the lipid parameters HDL were low and LDL was high, but the difference was not statistically significant. Body mass index and other lipid markers did not show any statistically significant difference between both the groups. Conclusions: EDS is high in post-MPW even when lipid parameters and CRP remain within the normal limits in post-MPW without comorbidities. EDS serves as a surrogate marker of estrogen deficiency and cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
NithyaPriyadharsini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: